Dr. Lal PathLabs Limited (LALPATHLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 219.03B |
| Enterprise Value | 218.59B |
| P/E Ratio | 58.16 |
| PEG Ratio | 6.56 |
| Price/Sales Ratio | 11.18 |
| Price/Book Ratio | 12.4 |
| Enterprise/Revenue | 10.9 |
| Enterprise/EBITDA | 35.04 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 27.63B |
| Revenue/Share | 180.82 |
| Gross Profit | 11.61B |
| EBITDA | 8.54B |
| Net Income | 5.05B |
| Diluted EPS | 30.2 |
Balance Sheet
| Total Cash | 16.07B |
| Total Cash/Share | 95.76 |
| Total Debt | 2.33B |
| Total Debt/Equity | 0.09 |
| Current Ratio | 3.86 |
| Book Value Per Share | 165.64 |
Price History
| 52-Week Change | 32.42 |
| 52-Week High | 2,079 |
| 52-Week Low | 1,272.6 |
| Moving Average 50 Days | 1,921.05 |
| Moving Average 200 Days | 1,663.44 |
Statistics
| Average Volume | 281,238 |
| Shares Outstanding | 167.21M |
| % Held by Institutions | 0.08 |
Dividend And Splits
| Trailing Annual Dividend Rate | 17.5 |
| Trailing Annual Dividend Yield | 0.86 |
| Payout Ratio | 0.18 |
| Last Split Factor | 2:1 |
| Last Split Date | December 19, 2025 |
AD
